CLXT Calyxt

Calyxt Doubles 2018 High Oleic Soybean Acres

(NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused company, announced today that it has contracted over 34,000 acres of its High Oleic Soybean with more than 100 farmers in the upper Midwest region including South Dakota, Minnesota, Iowa and Nebraska. With this number of acres secured for 2019, the company has doubled the 17,000 acres planted in 2018.

“We are pleased that growers are seeing the value of planting Calyxt High Oleic Soybean,” said Jim Blome, CEO of Calyxt. “Not only are they receiving better revenues from additional premiums, but we have expanded seed company purchasing options and allowed them to be closer to the consumer through our Identity Preserved Program. These benefits position Calyxt as a strong partner for other global food brands who are looking to increase sustainability and traceability.”

Calyxt’s Identity Preserved Program is a unique supply chain model that encompasses seed and grain production, processing of soybean and selling to food industry customers in order to deliver a high-quality, premium product to consumers. This allows food manufacturers to provide full traceability of ingredients in the brand to the county in which crop was grown, and potentially, even to the grower level in the future.

Calyxt growers collectively farm over 300,000 acres, with 40% of these acres producing soybean. It is estimated that 22% of the soybean planted will now be Calyxt High Oleic Soybean, increasing the average High Oleic Soybean acres per grower from 218 acres to 312 acres.

“Partnering with Calyxt as a grower has benefited my business in multiple ways,” said Kent Mettler, Calyxt Grower from Yankton County, SD. “Just last year, I entered into the South Dakota Soybean Association yield contest with 57 bushels per acre. I’m excited to see how my 2019 crop grows.”

Increase in total acreage can be attributed to the high retention rate of growers from 2018, with over 70% of growers returning to Calyxt’s High Oleic Soybean program. These repeat growers have increased their acres committed in 2019 to Calyxt High Oleic Soybean by 42% versus last year.

“Calyxt has reached this important milestone within the first three months of launching its High Oleic Soybean program,” commented Manoj Sahoo, Calyxt’s Chief Commercial Officer. “This shows that growers are embracing innovation and are excited to grow crops with healthier traits, a demand which consumers have been making at their grocery stores.”

About Calyxt

Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. Calyxt is pioneering a paradigm shift to deliver healthier food ingredients, such as healthier oils and high fiber wheat, for consumers and crop traits that benefit the environment and reduce pesticide applications, such as disease tolerance, for farmers. Calyxt develops non-transgenic crops leveraging processes that occur in nature by combining its leading gene-editing technology and technical expertise with its innovative commercial strategy. Calyxt is located in Minneapolis-St. Paul, Minn., and is listed on the Nasdaq market (ticker: CLXT).

For further information please visit our website:

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.

TALEN® is a registered trademark owned by the Cellectis S.A.

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in Calyxt’s Annual Report on Form 10-K, and Cellectis’ Annual Report on Form 20-F and the financial report (including the management report) for the year ended December 31, 2017 along with other Calyxt and Cellectis subsequent filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by applicable laws.

EN
22/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calyxt

Calyxt Inc: 1 director

A director at Calyxt Inc bought 20,000 shares at 3.206USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Fourth Quarter and Full Year 2020 Financial Results Con...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 4, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome and Chief Financial Officer Bill Koschak will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome, Chief Financial Officer Bill Koschak, Chief Business Development and Supply Chain Officer Manoj Sahoo and Senior Vice President of Sales & Marketing Keith Blanks will host the conference call, followed by a question a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch